Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 16, 2007 - Issue 7
Submit an article Journal homepage
50
Views
1
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Does a selective muscarinic receptor (M3) antagonist enhance the efficacy through oral delivery in chronic obstructive pulmonary disease patients?

LU S, PAREKH DD, KUZNETSOVA O et al.: An oral selective M3 cholinergic receptor antagonist in COPD. Eur. Respir. J. (2006) 28:772-780.

Krishna S Naruganahalli Ranbaxy Research Laboratories, Department of Pharmacology, New Drug Discovery Research, Plot 20, Sector 18, Gurgaon-122 015, Haryana, India. [email protected]
Pages 1127-1130 | Published online: 26 Jun 2007

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (1)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.